Cargando…
Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus
Cutaneous lupus erythematosus (CLE) is an autoimmune disorder like systemic lupus erythematosus (SLE). Both SLE and CLE characterize autoantibody secretion and immune cell recruitment. In particular, CLE can be divided into three more frequent types, varying in the severity of the skin lesions they...
Autores principales: | Soto, Jorge A., Melo-González, Felipe, Riedel, Claudia A., Bueno, Susan M., Kalergis, Alexis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504747/ https://www.ncbi.nlm.nih.gov/pubmed/36142624 http://dx.doi.org/10.3390/ijms231810706 |
Ejemplares similares
-
New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
por: Diethelm-Varela, Benjamín, et al.
Publicado: (2023) -
Modulation of Tumor Immunity by Soluble and Membrane-Bound Molecules at the Immunological Synapse
por: González, Pablo A., et al.
Publicado: (2013) -
Modulation of host adaptive immunity by hRSV proteins
por: Espinoza, Janyra A, et al.
Publicado: (2014) -
Nucleic Acid Immunity in the Pathogenesis of Cutaneous Lupus Erythematosus
por: Günther, Claudia
Publicado: (2019) -
Contribution of autophagy to antiviral immunity
por: Rey-Jurado, Emma, et al.
Publicado: (2015)